Karyopharm Therapeutics Inc. (KPTI): Price and Financial Metrics

KPTI POWR Grades

• Growth is the dimension where KPTI ranks best; there it ranks ahead of 85.98% of US stocks.
• The strongest trend for KPTI is in Growth, which has been heading up over the past 177 days.
• KPTI ranks lowest in Momentum; there it ranks in the 3rd percentile.

KPTI Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for KPTI is -2.05 -- better than only 4.54% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -4.44 for KARYOPHARM THERAPEUTICS INC; that's greater than it is for only 3.64% of US stocks.
• KARYOPHARM THERAPEUTICS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -123.57%, greater than the shareholder yield of just 4.71% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to KARYOPHARM THERAPEUTICS INC, a group of peers worth examining would be FCEL, TVTX, WATT, MIMO, and CASA.
• KPTI's SEC filings can be seen here. And to visit KARYOPHARM THERAPEUTICS INC's official web site, go to www.karyopharm.com.

KPTI Valuation Summary

• KPTI's price/sales ratio is 0.9; this is 52.63% lower than that of the median Healthcare stock.
• KPTI's price/sales ratio has moved down 1022 over the prior 120 months.

Below are key valuation metrics over time for KPTI.

KPTI Growth Metrics

The 4 year net cashflow from operations growth rate now stands at -96.91%.
• The 3 year revenue growth rate now stands at 1043.08%.
• Its 4 year cash and equivalents growth rate is now at 682.73%.

KPTI's revenue has moved up $98,198,000 over the prior 34 months.

The table below shows KPTI's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	157.074	-149.554	-165.291
2022-09-30	249.763	-97.236	-88.065
2022-06-30	251.307	-92.821	-103.553
2022-03-31	234.229	-113.425	-108.073
2021-12-31	209.819	-107.116	-124.088
2021-09-30	118.65	-163.225	-206.229

KPTI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• KPTI has a Quality Grade of C, ranking ahead of 58.11% of graded US stocks.
• KPTI's asset turnover comes in at 0.338 -- ranking 138th of 681 Pharmaceutical Products stocks.
• CAPR, DRNA, and PLXP are the stocks whose asset turnover ratios are most correlated with KPTI.

The table below shows KPTI's key quality metrics over time.